Enclosed is the press release for the financial results for the quarter ended September 30, 2026.

-------------------------------------------------------------------------------------------------------------------------------------------------------- November 5, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Press Release – Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. Press Release in respect of Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026, is enclosed herewith. Request you to take it on record and disseminate the same on your website. Thanking you. Yours sincerely, Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400 708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 PRESS RELEASE IKS Health’s Q2 FY27 Earnings Reflect Strong Momentum with 104 % Revenue and 62.5% EBITDA YoY Growth ● Q2 Revenue growth 103.9% YoY, 78.2% QoQ in INR, 87.3% YoY in USD ● Q2 EBITDA up 62.5% YoY; 49.7% QoQ ● PAT up 20.4% YoY; 12.4% QoQ ● EBITDA Margin 27.7% ; PAT Margin 13.7% ● TruBridge acquisition PAT/EPS accretive from Q2 FY’27 itself Mumbai, India | November 05, 2026: Inventurus Knowledge Solutions Limited (NSE: IKS), a leading technology-enabled healthcare solutions provider and care enablement platform for US healthcare, announced its financial results for the second quarter ended September 30, 2026 (Q2 FY27). Driven by continued momentum across its care enablement platform, the company delivered strong revenue and EBITDA growth, alongside the successful consolidation of TruBridge (82 days). Key Financial Highlights: Q2 FY 2027 Q2 FY 2026 Q1 FY 2027 Growth Revenue (INR Mn) 15,925 7,811 8,936 103.9% YoY; 78.2% QoQ EBITDA (INR Mn) 4,415 2,718 2,949 62.5% YoY; 49.7% QoQ PAT (INR Mn) 2,177 1,807 1,937 20.4% YoY; 12.4% QoQ “During Q2 FY27, IKS Health reached a defining inflection point by starting to operationalize the combined strengths of IKS Health and TruBridge. The integration advances the company’s vision to build an AI-native intelligent operating system for healthcare that enables clinical enterprises to transform operations, accelerate revenue and cash generation, improve quality of care, and be financially sustainable,” said Sachin K. Gupta, Founder and Global CEO, IKS Health. “Our expanding engagements with existing clients, alongside new account wins and cross-sell momentum, underscore the strong market demand for our value proposition.” Nithya Balasubramanian, Group CFO, IKS Health said, “Our performance in Q2 FY27 reflects the structural expansion of our operating scale and earnings power. Delivering INR 15,925 Mn in revenue, up 78.2% QoQ, demonstrates early financial accretion of the TruBridge integration alongside sustained organic revenue momentum. More importantly, operating discipline enabled robust EBITDA conversion, protecting margins as we scale. Over the coming quarters, our focus will remain squarely on realizing operational synergies, strengthening return profiles, and driving sustainable, long-term shareholder value.” Key Customer wins: ● White-Wilson Medical Center: Comprehensive RCM optimization partnership with White-Wilson Medical Center in Northwest Florida, a large multi-specialty group providing primary, specialty, imaging, and lab care. The partnership spans end-to-end RCM and scheduling, establishing IKS Health as a growth partner to scale rapidly with clinical support and value-based care. ● Evolve Orthopedic Partners: A physician-led, New York-based orthopedic and ambulatory surgery center MSO, leverages IKS Health's end-to-end RCM services. Building on this partnership, implementation is already underway as Evolve deploys MyCareHub, IKS Health's intelligent patient access platform, at OrthoNY to transform front-end operations across the specialty practice. ● Augusta Health: IKS Health’s established relationship with Augusta Health continues to grow alongside their clinical and operational priorities. Current work spans EHR data migration, validation, orthopedic migration support, and document processing. A proposed expansion into coverage verification would extend into ongoing RCM support in Augusta’s new EMR workflows. ● UMass Memorial Health: Strategic data migration partnership with Central MA’s largest not-for-profit system and partner of UMass Chan Medical School. Following Milford Regional integration, Migrate is consolidating legacy records into UMM’s Epic environment, expanding to the parent enterprise and establishing a repeatable model for future integrations. ● MISH Hospital & Clinics: TruBridge has partnered with MISH Hospital, a specialty surgical hospital in Lenexa, Kansas, serving patients in the Kansas City region. MISH will implement a unified EHR platform, where patient information and clinical workflows will combine into a single, integrated EHR, better positioning MISH to streamline operations, improve access, reduce tech complexity, and support more coordinated care. Safe Harbour Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. It is not possible to undertake to update any such statement that may have been made from time to time. —--------------------------------------------------------------------------------------------------------------------- About IKS Health IKS Health reduces the administrative, clinical, and operational burdens that slow healthcare down, giving clinicians and care teams the freedom to focus on delivering exceptional care. Through its Care Enablement platform, IKS Health integrates AI, agentic workflows, and human expertise to create smarter operations, better outcomes, and financially sustainable growth across the care journey. Founded in 2006 and recognized by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with the 2025 DORA Award for “Augmenting Human Expertise with AI,” IKS Health partners with the largest health systems, physician groups, and specialty practices across the United States. Learn more at ikshealth.com. Inventurus Knowledge Solutions Limited was listed on National Stock Exchange of India Limited (NSE) and BSE Limited (Bombay Stock Exchange) on December 19, 2024. {Scrip codes: NSE - IKS and BSE - 544309} MEDIA CONTACT - IKS HEALTH INVESTOR RELATIONS CONTACT - IKS HEALTH Sameer Arora Saransh Mundra Senior Vice President Vice President press@ikshealth.com investor_relations@ikshealth.com -xx-xx-xx-